Endothelial dysfunction and inflammatory and mitochondrial microRNAs as therapeutic targets to reduce cardiovascular complications in type 2 diabetes mellitus: evaluation of the effects of melatonin.
Study of the effects of melatonin on endothelial dysfunction and the expression of circulating microRNAs in primary culture models and animal models, with the aim of considering a clinical trial in diabetic patients in the future.